Condition: Prolactinoma · Sponsor: University Hospital, Basel, Switzerland
This randomized, active-controlled, parallel-arm, single-blind trial is to compare the effects of Dopamine agonists (DA) therapy targeting different established treatment strategies on glucose metabolism assessed by an oral glucose tolerance test.
This description comes directly from the study's public registry record.
Cihan Atila, Dr. · +41 61 328 4579 · cihan.atila@usb.ch
Always discuss trial participation with your own doctor first.
| University Hospital Basel, Dept. of Endocrinology, Metabolism & Diabetes | Basel, Switzerland | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07045935